Adenosine-A2A receptor antagonist CPI-444

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A small molecule immune checkpoint inhibitor of the adenosine A2A receptor (ADORA2A) with potential antineoplastic activity. Upon oral administration, adenosine-A2A receptor antagonist CPI-444 binds to adenosine A2A receptors expressed on the surface of immune cells, including T-lymphocytes, natural killer (NK) cells, macrophages and dendritic cells (DCs). This prevents tumor-released adenosine from interacting with the A2A receptors on these key immune surveillance cells, thereby abrogating adenosine-induced immunosuppression in the tumor microenvironment. This may stimulate anti-tumor immune responses, resulting in tumor regression.

External links

Medicine icon
Medicine icon

This WikiMD article Adenosine-A2A receptor antagonist CPI-444 is a stub. If you are familiar with the topic Adenosine-A2A receptor antagonist CPI-444, you can help us. Paid editors welcome!


Adenosine-A2A receptor antagonist CPI-444 is part of WikiMD's free ^articles!

^Adenosine-A2A receptor antagonist CPI-444 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available